NCT03993067View on ClinicalTrials.gov

Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery.

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

January 15, 2020

Study Completion Date

January 15, 2020

Conditions
Biliary FistulaSurgery
Interventions
PROCEDURE

Hemopatch

Hemopatch is a collagen based sealant is a hemostat agent. We want to investigate his role in the prevention of post operative biliary fistula

PROCEDURE

Fribrin glue and Tabotamp

Fibrin glue and Tabotampis the standard treatment

Trial Locations (1)

20089

Department of Hepatobiliary and General Surgery, Humanitas Research Hospital, University of Milan, Rozzano

All Listed Sponsors
lead

University of Milan

OTHER

NCT03993067 - Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery. | Biotech Hunter | Biotech Hunter